| Torrance Memorial Physician Network | |
|
3333 Skypark Dr Suite 100 Torrance CA 90505-5023 | |
| (310) 784-6300 | |
| (310) 891-6758 |
| Full Name | Torrance Memorial Physician Network |
|---|---|
| Speciality | Family Medicine |
| Location | 3333 Skypark Dr, Torrance, California |
| Authorized Official Name and Position | Heidi Assigal (VICE PRESIDENT) |
| Authorized Official Contact | 3102577205 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Torrance Memorial Physician Network 23326 Hawthorne Blvd Suite 200 Torrance CA 90505-3725 Ph: (310) 257-7205 | Torrance Memorial Physician Network 3333 Skypark Dr Suite 100 Torrance CA 90505-5023 Ph: (310) 784-6300 |
| NPI Number | 1083903124 |
|---|---|
| Provider Enumeration Date | 03/29/2011 |
| Last Update Date | 04/10/2024 |
| Medicare PECOS PAC ID | 1355302134 |
|---|---|
| Medicare Enrollment ID | O20110819000276 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083903124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Ankush Chhabra |
|---|---|
| Provider Type | Practitioner - Peripheral Vascular Disease |
| Provider Identifiers | NPI Number: 1750308318 PECOS PAC ID: 7810800158 Enrollment ID: I20031111000903 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Heidi Hoffman |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1669426409 PECOS PAC ID: 1850295478 Enrollment ID: I20031124000835 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Deepjot K Singh |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1093817843 PECOS PAC ID: 8022912641 Enrollment ID: I20031124000837 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Robin E Kaminsky |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1821038035 PECOS PAC ID: 6305743279 Enrollment ID: I20031217001102 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Daniel M Zinar |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1720074461 PECOS PAC ID: 8628979143 Enrollment ID: I20040117000135 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David H Wallis |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255383139 PECOS PAC ID: 8921992199 Enrollment ID: I20040209001308 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hakimeh B Kadivar |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1679560320 PECOS PAC ID: 9931094091 Enrollment ID: I20040217001179 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Aqdas S Kuraishi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306880596 PECOS PAC ID: 3577458611 Enrollment ID: I20040218000434 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David Chan |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1972591378 PECOS PAC ID: 6204733579 Enrollment ID: I20040220001011 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Valente C Ramos |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1437179066 PECOS PAC ID: 3476449695 Enrollment ID: I20040225000334 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Maria K Lui |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134172885 PECOS PAC ID: 5395659718 Enrollment ID: I20040304001385 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Joe Nakagawa |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1346257854 PECOS PAC ID: 1153219399 Enrollment ID: I20040309000345 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mitchell Parver |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1912959438 PECOS PAC ID: 4183513328 Enrollment ID: I20040315000322 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Katrina M Vlachos |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1932126802 PECOS PAC ID: 2567353782 Enrollment ID: I20040324001239 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nicole K Alexander-spencer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528175395 PECOS PAC ID: 4486546173 Enrollment ID: I20040326001249 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Alexander J Shen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1710091723 PECOS PAC ID: 6507850187 Enrollment ID: I20040414001468 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Victoria Y Shin |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1841481173 PECOS PAC ID: 5698764512 Enrollment ID: I20040506001743 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sarwatt Mahmud |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1982785713 PECOS PAC ID: 5193714517 Enrollment ID: I20040511000527 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tiffany Rogers |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1295725026 PECOS PAC ID: 7517958200 Enrollment ID: I20040520001579 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | John Louie Go |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1982643060 PECOS PAC ID: 1850375239 Enrollment ID: I20040614001669 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Deren M Sinkowitz |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1619957750 PECOS PAC ID: 9830178458 Enrollment ID: I20040716001078 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Zachary A Gray |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1699791517 PECOS PAC ID: 8628058385 Enrollment ID: I20040722001045 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Paul J Brown |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003862376 PECOS PAC ID: 6901877497 Enrollment ID: I20040805001695 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michelle A Charfen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1588602486 PECOS PAC ID: 3072587641 Enrollment ID: I20040820000679 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Bradley C Mcafee |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1740206945 PECOS PAC ID: 2769456649 Enrollment ID: I20040826001418 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jasminka M Criley |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1174535017 PECOS PAC ID: 8426024738 Enrollment ID: I20040908000974 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Rosanne Kay |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1346332293 PECOS PAC ID: 7810965100 Enrollment ID: I20040924000453 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Peter W Joyce |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1902848914 PECOS PAC ID: 3274592373 Enrollment ID: I20041005000757 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David Ira Cohen |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1730273764 PECOS PAC ID: 2668431552 Enrollment ID: I20041006001013 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Katherine V Miller |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1750370060 PECOS PAC ID: 1850354515 Enrollment ID: I20041104000652 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michael P Tarnay |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1598866642 PECOS PAC ID: 2163488230 Enrollment ID: I20041209000854 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Elisa I Anhalt |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1194773424 PECOS PAC ID: 8325005424 Enrollment ID: I20041209001093 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Darren Lee Bedolla |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1114956299 PECOS PAC ID: 3476510579 Enrollment ID: I20041209001113 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | George J So |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1821041195 PECOS PAC ID: 5193782290 Enrollment ID: I20041209001117 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Stephen L Nuccion |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1427165703 PECOS PAC ID: 3375500523 Enrollment ID: I20041220000357 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ricardo E Huete |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1184630683 PECOS PAC ID: 0648229450 Enrollment ID: I20050119000762 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Chad M Venne |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1730237520 PECOS PAC ID: 2567413958 Enrollment ID: I20050202000952 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mitchell J Sklar |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1619929122 PECOS PAC ID: 1557313459 Enrollment ID: I20050218000813 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | William Weitin Tarng |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376545723 PECOS PAC ID: 4486551751 Enrollment ID: I20050225000834 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ujjwala S Dheeriya |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1770508582 PECOS PAC ID: 7911950936 Enrollment ID: I20050301000992 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Dawn L Brandewie |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1316064652 PECOS PAC ID: 4385681212 Enrollment ID: I20050412001500 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Marcia S Blank |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1962570051 PECOS PAC ID: 3779522073 Enrollment ID: I20050426001469 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mark D Lurie |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1326057670 PECOS PAC ID: 8628018017 Enrollment ID: I20050504001239 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Andrew G Horodner |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1386849974 PECOS PAC ID: 8224072202 Enrollment ID: I20050611000011 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kalpana S Hool |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629043799 PECOS PAC ID: 7012952401 Enrollment ID: I20050627000339 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | John T Abe |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1578542569 PECOS PAC ID: 3678500147 Enrollment ID: I20050726001054 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Fred L Reitler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245280940 PECOS PAC ID: 3678506193 Enrollment ID: I20050915000305 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jimmy C Huang |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1376574624 PECOS PAC ID: 6002841715 Enrollment ID: I20050930000850 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lauren E Choi |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1699736132 PECOS PAC ID: 0941225551 Enrollment ID: I20051012001234 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Anna Mellor |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316998776 PECOS PAC ID: 4789617200 Enrollment ID: I20051115001103 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Frances A Mckindsey |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1568417434 PECOS PAC ID: 1355360660 Enrollment ID: I20051116000477 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Maria M Vollucci |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922181213 PECOS PAC ID: 3971524893 Enrollment ID: I20051207000660 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lee G Kissel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164473351 PECOS PAC ID: 5991727265 Enrollment ID: I20051229000799 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mark P Gellman |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1669493375 PECOS PAC ID: 8022022581 Enrollment ID: I20060203000438 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Russell W Dickerson |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1023062320 PECOS PAC ID: 5890685283 Enrollment ID: I20060208000881 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Anthony J Chen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1669430187 PECOS PAC ID: 6406863265 Enrollment ID: I20060321000200 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Khalid M Eltawil |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1396724399 PECOS PAC ID: 7810908605 Enrollment ID: I20060508000754 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mary R Doost |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902853419 PECOS PAC ID: 3779594973 Enrollment ID: I20060602000111 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mladen A Rasic |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1659313971 PECOS PAC ID: 0143233395 Enrollment ID: I20060711000308 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Donald B Striplin |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1104863323 PECOS PAC ID: 3274536636 Enrollment ID: I20060824000528 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | S John Whang |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1851346548 PECOS PAC ID: 5294774881 Enrollment ID: I20060831000330 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Dilrukshie V Cooray |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1366548646 PECOS PAC ID: 8729085758 Enrollment ID: I20061103000231 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Catherine J Lawson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1649279043 PECOS PAC ID: 1153321104 Enrollment ID: I20061222000192 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Khanh T Nguyen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1679667364 PECOS PAC ID: 7618979956 Enrollment ID: I20070215000305 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tanya Arvan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1104827666 PECOS PAC ID: 3274637426 Enrollment ID: I20070328000692 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Susan J Kaspian |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124162151 PECOS PAC ID: 7618075102 Enrollment ID: I20070606000760 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Donny N Baek |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1316075542 PECOS PAC ID: 1153420310 Enrollment ID: I20070628000524 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Asad U Khaja |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1679612360 PECOS PAC ID: 6608976766 Enrollment ID: I20070703000407 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ernest K Lee |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417032830 PECOS PAC ID: 5496840126 Enrollment ID: I20070926000912 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michael C Yu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366581290 PECOS PAC ID: 0941399323 Enrollment ID: I20071207000807 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Anahid J Kwiatkouski |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1780731810 PECOS PAC ID: 5092895946 Enrollment ID: I20080123000923 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Charles M Mehringer |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1487695136 PECOS PAC ID: 7810070141 Enrollment ID: I20080211000287 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Keri R Zickuhr |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1891993762 PECOS PAC ID: 6709955784 Enrollment ID: I20080516000145 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Thomas E Lowe |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1801968334 PECOS PAC ID: 1759453749 Enrollment ID: I20080708000635 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Cynthia H Ro |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1598946790 PECOS PAC ID: 7618044363 Enrollment ID: I20080922000271 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Amanda W Murphy |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1871794347 PECOS PAC ID: 8820157332 Enrollment ID: I20081112000382 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kelley A Prince |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174682124 PECOS PAC ID: 3577623834 Enrollment ID: I20081118000021 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Susan N Starr |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790936649 PECOS PAC ID: 7416018767 Enrollment ID: I20081205000267 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Eve L Makoff |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1659402576 PECOS PAC ID: 9931260700 Enrollment ID: I20081211000620 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Vanessa Vianey Hernandez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1891836425 PECOS PAC ID: 8921160656 Enrollment ID: I20081215000301 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tam B Tran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548448236 PECOS PAC ID: 5698839488 Enrollment ID: I20090128000580 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Courtney Zamzow |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1831344068 PECOS PAC ID: 6103981485 Enrollment ID: I20090220000161 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tauseef Haider |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194803312 PECOS PAC ID: 6103858865 Enrollment ID: I20090416000168 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Marc F Colman |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1548274947 PECOS PAC ID: 2163522665 Enrollment ID: I20090416000515 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Gene Hawkins |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1245328079 PECOS PAC ID: 3173671690 Enrollment ID: I20090511000161 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michael A Noronha |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1114003316 PECOS PAC ID: 5799853784 Enrollment ID: I20090512000150 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Cheryl Lynn Sanders |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1619948395 PECOS PAC ID: 1456401249 Enrollment ID: I20090617000350 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Soha Elgharib |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1528091170 PECOS PAC ID: 5991856452 Enrollment ID: I20090624000383 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Roy C Fu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1972686632 PECOS PAC ID: 1658423751 Enrollment ID: I20090721000655 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David D Rand |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1942271275 PECOS PAC ID: 1759434939 Enrollment ID: I20090805000631 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Clifford Liu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1831299528 PECOS PAC ID: 7517011364 Enrollment ID: I20090813000572 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Saadia R Chaudhary |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1194843326 PECOS PAC ID: 9931251246 Enrollment ID: I20090814000047 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jennifer Baars |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1578785218 PECOS PAC ID: 9032259585 Enrollment ID: I20091215000222 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Rumi Cader |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508898214 PECOS PAC ID: 9335247774 Enrollment ID: I20091229000348 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Milena Shakhbazona |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1043494313 PECOS PAC ID: 7517007339 Enrollment ID: I20091229000382 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Moin Salah |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386886190 PECOS PAC ID: 9032251103 Enrollment ID: I20100127000879 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mark F Adriatico |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1194913608 PECOS PAC ID: 9931242153 Enrollment ID: I20100210000042 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Brian R Miura |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1801820527 PECOS PAC ID: 5395871560 Enrollment ID: I20100326000385 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Don P Sanders |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1134235179 PECOS PAC ID: 9133186372 Enrollment ID: I20100326000630 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Carmen N Gossette |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225238850 PECOS PAC ID: 0648300772 Enrollment ID: I20100616000086 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Melvin Snyder |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1942388962 PECOS PAC ID: 4789629445 Enrollment ID: I20100809000217 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nosrat A Nabavi |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1336227263 PECOS PAC ID: 5294869095 Enrollment ID: I20100816000711 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Raju Hassanand Wadhwa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1023006103 PECOS PAC ID: 3375667413 Enrollment ID: I20100826000714 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Robert N Glazer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528044815 PECOS PAC ID: 0042334104 Enrollment ID: I20100826000919 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tracy E Bercu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1992927230 PECOS PAC ID: 1951426048 Enrollment ID: I20100913000977 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Andrew Lim |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1457468738 PECOS PAC ID: 5991701302 Enrollment ID: I20100915000700 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Robert D Swift |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699751693 PECOS PAC ID: 8527184795 Enrollment ID: I20100924000462 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Richard E Krauthamer |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1285685172 PECOS PAC ID: 5395754659 Enrollment ID: I20100924001302 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David N Stone |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1558313072 PECOS PAC ID: 3375552649 Enrollment ID: I20100927000179 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Rachel A Knopoff |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1114977717 PECOS PAC ID: 1456477223 Enrollment ID: I20100929000949 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Albert Grabb |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1003865783 PECOS PAC ID: 8921017294 Enrollment ID: I20100929001187 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Randolph Craig Ohara |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1114034477 PECOS PAC ID: 3779540919 Enrollment ID: I20101012000097 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nicholas Joseph Silvino |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1245347509 PECOS PAC ID: 7517926587 Enrollment ID: I20101018000389 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jerome Harold Unatin |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1619084969 PECOS PAC ID: 9234196478 Enrollment ID: I20101020000051 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Eduardo J Anorga |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235312752 PECOS PAC ID: 0446332837 Enrollment ID: I20101030000129 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Elaine K Jones |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700862729 PECOS PAC ID: 5193919108 Enrollment ID: I20101103001406 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Peter C Tseng |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1508921396 PECOS PAC ID: 3072700509 Enrollment ID: I20101209001261 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Eric C Nakkim |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1124123054 PECOS PAC ID: 0941499438 Enrollment ID: I20110114000237 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | James A Mckinnell |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1942403035 PECOS PAC ID: 3173702537 Enrollment ID: I20110201000363 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kari M Ogata |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699818385 PECOS PAC ID: 3678753456 Enrollment ID: I20110210001024 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Barbara L Schulz |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1740251420 PECOS PAC ID: 6002717212 Enrollment ID: I20110304000091 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Pavanjit M Brar |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033250774 PECOS PAC ID: 0547443830 Enrollment ID: I20110323001042 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Matthew W Ryan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255668836 PECOS PAC ID: 4082897376 Enrollment ID: I20110323001062 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Stephanie Lay Tang |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1720240526 PECOS PAC ID: 1153506662 Enrollment ID: I20110427000537 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Eric N Milefchik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851362131 PECOS PAC ID: 6709818271 Enrollment ID: I20110621000552 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ziba Jalali |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1902855232 PECOS PAC ID: 5597786855 Enrollment ID: I20110621000645 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Angelica M Malicdem |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1942271226 PECOS PAC ID: 3678751690 Enrollment ID: I20110622000297 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Samuel Sang-bum Nam |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1396936951 PECOS PAC ID: 5294904124 Enrollment ID: I20110811000183 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hosam Ahmad |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1881846475 PECOS PAC ID: 2668641135 Enrollment ID: I20110818000193 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Grace T Kiet |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1104023688 PECOS PAC ID: 6103096136 Enrollment ID: I20110831000458 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Rebecca R Hu |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1457640302 PECOS PAC ID: 9830360676 Enrollment ID: I20110927000495 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Amy A Yaghmai |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1821104274 PECOS PAC ID: 6002896610 Enrollment ID: I20111020000505 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David Howard Stern |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699798694 PECOS PAC ID: 0042483620 Enrollment ID: I20111026000586 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Brian D Sherman |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1942462056 PECOS PAC ID: 8224204201 Enrollment ID: I20111221000352 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Syed M Jilani |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1629067442 PECOS PAC ID: 1254507551 Enrollment ID: I20120109000769 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hugo Hool |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1417944489 PECOS PAC ID: 6002073350 Enrollment ID: I20120130000346 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Vanessa L Dickey |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1497742472 PECOS PAC ID: 6507023884 Enrollment ID: I20120130000645 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jason A Davis |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1053600940 PECOS PAC ID: 5193984433 Enrollment ID: I20120306000977 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Srinivas Yanamadala |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1346321510 PECOS PAC ID: 8123288453 Enrollment ID: I20120323000559 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jonathan K Park |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1720215486 PECOS PAC ID: 9830351790 Enrollment ID: I20120510000404 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Genevieve L Hasek |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1780848085 PECOS PAC ID: 7618130360 Enrollment ID: I20120517000142 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hovsep R Babayan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740435460 PECOS PAC ID: 7618130139 Enrollment ID: I20120521000521 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tasneem A Bholat |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1114151271 PECOS PAC ID: 5597928960 Enrollment ID: I20120522001098 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Alya D Torna |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306051024 PECOS PAC ID: 2062543788 Enrollment ID: I20120523000506 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Yusha Ikhtabar Siddiqui |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265662340 PECOS PAC ID: 2860648722 Enrollment ID: I20120808000430 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kristen G Kerekes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528328101 PECOS PAC ID: 8921255654 Enrollment ID: I20120830000658 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sharon M Walder |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568509693 PECOS PAC ID: 1355243445 Enrollment ID: I20120917000451 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sadia S Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225271125 PECOS PAC ID: 2668621558 Enrollment ID: I20121010000025 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jennifer B Michael |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1366612749 PECOS PAC ID: 2264620707 Enrollment ID: I20121108000161 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Richard H Huynh |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1184858243 PECOS PAC ID: 3274784152 Enrollment ID: I20121127000699 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Taraneh Tehrani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1689731648 PECOS PAC ID: 2264587534 Enrollment ID: I20121231000007 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michelle G Barhaghi |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1104083922 PECOS PAC ID: 5698947281 Enrollment ID: I20130708000246 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Gina P Nguyen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619265022 PECOS PAC ID: 9335380690 Enrollment ID: I20130729000804 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Natalie Zelta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689962664 PECOS PAC ID: 2567613771 Enrollment ID: I20130812000141 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mary Cecilia Hannon |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1275824518 PECOS PAC ID: 5991966350 Enrollment ID: I20130813000508 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Elisabeth A Jannicky |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1538397674 PECOS PAC ID: 6406003904 Enrollment ID: I20130820000438 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tiffany T Trinh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1891007084 PECOS PAC ID: 2567605025 Enrollment ID: I20130830000617 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lisa M Coles |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1578751129 PECOS PAC ID: 2163597469 Enrollment ID: I20131031001622 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ana Lopez Osullivan |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1235363193 PECOS PAC ID: 8022244540 Enrollment ID: I20131111001462 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Monquen Huang |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1477782035 PECOS PAC ID: 8921234253 Enrollment ID: I20131115000302 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Babar Saeed |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1093989618 PECOS PAC ID: 2365588340 Enrollment ID: I20140111000317 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hung Nguyen |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1255590444 PECOS PAC ID: 9234368937 Enrollment ID: I20140129000259 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Christopher M Hoshino |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1881881431 PECOS PAC ID: 7315177979 Enrollment ID: I20140226001076 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Izzat Alamdari |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770881781 PECOS PAC ID: 6305060427 Enrollment ID: I20140611001717 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jung-ok Ha |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104092667 PECOS PAC ID: 8729153382 Enrollment ID: I20140618000016 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jayson Weir |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1518257138 PECOS PAC ID: 2163647355 Enrollment ID: I20140701002282 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Christina M Campbell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851584007 PECOS PAC ID: 7214153824 Enrollment ID: I20140716002238 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michelle Y Mcnee |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1083856868 PECOS PAC ID: 0648498238 Enrollment ID: I20140822001453 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Shannon Stacy |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1043373087 PECOS PAC ID: 8224257118 Enrollment ID: I20140908001201 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Christianne C Kisner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104247683 PECOS PAC ID: 6901128735 Enrollment ID: I20141208000015 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Dawn E Switzer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689898462 PECOS PAC ID: 2163746561 Enrollment ID: I20150113000401 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mary Beth Miller |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851331821 PECOS PAC ID: 2264595834 Enrollment ID: I20150122000010 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jessica L Gunderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144558503 PECOS PAC ID: 8921323759 Enrollment ID: I20150218002494 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Benedict T Chou |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1770759375 PECOS PAC ID: 6901123769 Enrollment ID: I20150317000231 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sunil S Hebbar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619236593 PECOS PAC ID: 3072834779 Enrollment ID: I20150605002988 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jeffrey Kim |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1457679631 PECOS PAC ID: 6002127149 Enrollment ID: I20150616002742 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ben Tseng |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1710206347 PECOS PAC ID: 5092026062 Enrollment ID: I20150617000728 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kevin L Mak |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1841559002 PECOS PAC ID: 0840502167 Enrollment ID: I20150629002999 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sasha Mejia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457742330 PECOS PAC ID: 7810201621 Enrollment ID: I20150806010491 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Keith Chumley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1932126653 PECOS PAC ID: 4688717846 Enrollment ID: I20150909002261 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lynn M Morton |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1588047922 PECOS PAC ID: 4486961265 Enrollment ID: I20150910001666 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Joe R Gamboa |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1598072779 PECOS PAC ID: 9931419595 Enrollment ID: I20151111000965 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Marianne E Hagiya |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770953531 PECOS PAC ID: 3375843501 Enrollment ID: I20151119002384 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Diana S Rios |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700259835 PECOS PAC ID: 9537460092 Enrollment ID: I20151229001236 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kurt A Hansen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1285925271 PECOS PAC ID: 0244535656 Enrollment ID: I20160223002030 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Patrick J Pan |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1326471624 PECOS PAC ID: 1254630171 Enrollment ID: I20160427002302 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Prasun Ramakrishnan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1811147887 PECOS PAC ID: 7618149964 Enrollment ID: I20160510001791 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Vladimir Labalo |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1871880716 PECOS PAC ID: 0446542773 Enrollment ID: I20160707001054 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kristen M Gutermuth |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558386243 PECOS PAC ID: 3375670979 Enrollment ID: I20160719000084 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kate E Niehoff |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114364338 PECOS PAC ID: 0547583056 Enrollment ID: I20160726002718 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kim Mai T Nguyen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1417185588 PECOS PAC ID: 3375706468 Enrollment ID: I20160808000675 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Swati Sikaria |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1497048060 PECOS PAC ID: 5799079778 Enrollment ID: I20160815001264 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ajit Singh Mannan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1659613719 PECOS PAC ID: 5890097125 Enrollment ID: I20160823003116 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Roseann S Chu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831532282 PECOS PAC ID: 1951697630 Enrollment ID: I20160906002150 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nicole D Lee |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487094918 PECOS PAC ID: 9739475146 Enrollment ID: I20160912001607 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Keyur A Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558595355 PECOS PAC ID: 0143472258 Enrollment ID: I20160913002833 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Anshu K Buttan |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1093158891 PECOS PAC ID: 9133416555 Enrollment ID: I20160928000759 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lindsey E Brucker |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1669762688 PECOS PAC ID: 0840579223 Enrollment ID: I20161108002226 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Gaurav Banka |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205129731 PECOS PAC ID: 0042590960 Enrollment ID: I20161212002296 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Panteha Rezaeian |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295155109 PECOS PAC ID: 6709167026 Enrollment ID: I20161228002303 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Deborah Wallach |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326594144 PECOS PAC ID: 7315229416 Enrollment ID: I20170125002283 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jenny Luo |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1275807281 PECOS PAC ID: 3375760879 Enrollment ID: I20170503001971 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Deepak H Singh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1023428851 PECOS PAC ID: 3072890763 Enrollment ID: I20170505001863 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Frank Kuo |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1922418797 PECOS PAC ID: 6406075803 Enrollment ID: I20170509001856 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hana Lim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1992124333 PECOS PAC ID: 9931499670 Enrollment ID: I20170530002189 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Teresa J Kim |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386078327 PECOS PAC ID: 0648547109 Enrollment ID: I20170605001230 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ayushi Desai |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376953240 PECOS PAC ID: 4082982939 Enrollment ID: I20170616001417 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ahad A Shiraz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356683932 PECOS PAC ID: 9830477041 Enrollment ID: I20170830004047 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Gary Tsai |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629495585 PECOS PAC ID: 4688807423 Enrollment ID: I20170922003557 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hiva Bastanmehr |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396751194 PECOS PAC ID: 3476829441 Enrollment ID: I20171018001781 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Stefanie I Lu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164934931 PECOS PAC ID: 8729346648 Enrollment ID: I20171227000220 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Leah N Robinson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386150431 PECOS PAC ID: 3678834710 Enrollment ID: I20180306000712 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jamie Kagihara |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1245590447 PECOS PAC ID: 7113289554 Enrollment ID: I20180322001015 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | W Alexander Ellis |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083075303 PECOS PAC ID: 1456616366 Enrollment ID: I20180524001004 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Veronica Solorio |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1932581980 PECOS PAC ID: 2567717598 Enrollment ID: I20180615001122 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sina Samie |
|---|---|
| Provider Type | Practitioner - Pain Management |
| Provider Identifiers | NPI Number: 1992191514 PECOS PAC ID: 8527337435 Enrollment ID: I20180618002215 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Omar Aly |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265724389 PECOS PAC ID: 9638398472 Enrollment ID: I20180817003143 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Elizabeth A Harleston |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194089789 PECOS PAC ID: 1052537511 Enrollment ID: I20180907000245 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | John P Andrawis |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1861744419 PECOS PAC ID: 1759655152 Enrollment ID: I20180907001962 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | John S Mense |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588051171 PECOS PAC ID: 9537410196 Enrollment ID: I20180920000206 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Zareen S Choudhury |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134521784 PECOS PAC ID: 5799037628 Enrollment ID: I20181004000600 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Joshua A Tarpley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790179935 PECOS PAC ID: 0143508200 Enrollment ID: I20181015000789 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Manuel Hakimi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1063873891 PECOS PAC ID: 2668724907 Enrollment ID: I20181015001394 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Christina C Hanisch |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568905990 PECOS PAC ID: 9537432323 Enrollment ID: I20181023000323 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Daniel Pechstedt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831597756 PECOS PAC ID: 5698019909 Enrollment ID: I20181127002237 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Rachel Cho |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720599483 PECOS PAC ID: 3678817327 Enrollment ID: I20181206000997 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Carole J Hauser |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083816508 PECOS PAC ID: 2668716325 Enrollment ID: I20181206001472 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Alexandra N Grossman |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1467815936 PECOS PAC ID: 0840536348 Enrollment ID: I20190103002218 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sandra Isnasious |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1174908685 PECOS PAC ID: 7810238227 Enrollment ID: I20190412000962 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tara C Bartlett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124386347 PECOS PAC ID: 8325381296 Enrollment ID: I20190515003421 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Phillip Lyle Pangan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831672724 PECOS PAC ID: 1153654298 Enrollment ID: I20190605001394 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | David Sehwan Kim |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1043552508 PECOS PAC ID: 9032338488 Enrollment ID: I20190615000269 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Francisco N Alvarez |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1558724823 PECOS PAC ID: 6204134026 Enrollment ID: I20190628002528 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Matthew R Mejia |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1013371400 PECOS PAC ID: 1850628314 Enrollment ID: I20190807001790 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Richard Harold Bracken |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1598127284 PECOS PAC ID: 4486919826 Enrollment ID: I20190809001879 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mercedeh Modir Shanechi |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1275914350 PECOS PAC ID: 4082912381 Enrollment ID: I20190827001728 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kaylan N Mavrich |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174039143 PECOS PAC ID: 2668701384 Enrollment ID: I20190905003419 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kim M Lee |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1609275171 PECOS PAC ID: 5597094011 Enrollment ID: I20190909003779 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Samuel W Tomich |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1871947390 PECOS PAC ID: 2163753393 Enrollment ID: I20191018001621 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Xuan H Valdez |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1396108197 PECOS PAC ID: 8729310685 Enrollment ID: I20191025000103 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Shintau Lin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1942683487 PECOS PAC ID: 2365793593 Enrollment ID: I20191104001888 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Esmeralda Guerrero |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487905543 PECOS PAC ID: 5890086839 Enrollment ID: I20191114003307 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jason P Alvarado |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306229844 PECOS PAC ID: 7416389820 Enrollment ID: I20191122000795 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Justin Wayne Wong Tiulim |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457892861 PECOS PAC ID: 9133471105 Enrollment ID: I20191122001323 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Fereshteh Rajabi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912361700 PECOS PAC ID: 1951695162 Enrollment ID: I20191216001152 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Heather Garza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699246371 PECOS PAC ID: 9335574516 Enrollment ID: I20200116000248 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Tiffany L Hsu |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1740642248 PECOS PAC ID: 4284069105 Enrollment ID: I20200122002167 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nidhi Agarwal |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1518387125 PECOS PAC ID: 1759633233 Enrollment ID: I20200210001353 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Khoi M Le |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1043746639 PECOS PAC ID: 6305274960 Enrollment ID: I20200312001561 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sarah L An |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881213874 PECOS PAC ID: 5395176242 Enrollment ID: I20200511001187 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Arielle M Davidson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043847130 PECOS PAC ID: 7719318120 Enrollment ID: I20200518002510 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sakara Seng |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114472446 PECOS PAC ID: 1052732369 Enrollment ID: I20200521002619 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Neda Rouhi Brojeni |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225558919 PECOS PAC ID: 0648692319 Enrollment ID: I20200625001673 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Daniel Chiou |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1427402403 PECOS PAC ID: 2567885635 Enrollment ID: I20200708000681 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sunetris Fluellen |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1164871513 PECOS PAC ID: 0143512624 Enrollment ID: I20200723001021 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hardeep K Chohan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1396272647 PECOS PAC ID: 7810311818 Enrollment ID: I20200723001714 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Joseph S Roofeh |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1033572854 PECOS PAC ID: 8325339112 Enrollment ID: I20200727001553 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Eriko Masuda |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1992123095 PECOS PAC ID: 5991076440 Enrollment ID: I20200731002588 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jessica Siak |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1174059570 PECOS PAC ID: 2961829163 Enrollment ID: I20200902002556 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | George K Hanna |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1609212281 PECOS PAC ID: 1759655376 Enrollment ID: I20200923002283 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Bhavesh N Ramani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285054635 PECOS PAC ID: 3779859624 Enrollment ID: I20201106001609 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Michael Sidney Reich |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1710413885 PECOS PAC ID: 7810264280 Enrollment ID: I20201109001170 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Sara M Kanamori |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851755508 PECOS PAC ID: 0941618573 Enrollment ID: I20210421000696 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Arash Aghel |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1477729713 PECOS PAC ID: 5890915763 Enrollment ID: I20210423000925 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Cristina P Moldovan |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1346834512 PECOS PAC ID: 7214336890 Enrollment ID: I20210602000898 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Megan Jean Sue |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1528421989 PECOS PAC ID: 2466862941 Enrollment ID: I20210616003736 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Alexander J Gertel |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1003270117 PECOS PAC ID: 4082908942 Enrollment ID: I20210618002160 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Lorena M Layrisse Landaeta |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538589965 PECOS PAC ID: 0547662009 Enrollment ID: I20210707002015 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Angud S Mehdi |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1457885279 PECOS PAC ID: 6305248394 Enrollment ID: I20210713003848 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Henry J Kaing |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1487186433 PECOS PAC ID: 8820332992 Enrollment ID: I20210723001313 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Hazem G Abdelsalam |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346793312 PECOS PAC ID: 9537573530 Enrollment ID: I20210802001988 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nadia Jafar Curran |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1639564610 PECOS PAC ID: 9032515010 Enrollment ID: I20210831002835 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Nima M Moghadam |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1235621590 PECOS PAC ID: 7214334945 Enrollment ID: I20210923000998 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Betty P Lo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1609143288 PECOS PAC ID: 6103126321 Enrollment ID: I20211022000677 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mona Madani |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891112223 PECOS PAC ID: 5991062960 Enrollment ID: I20211026000537 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Kevin Kapur |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1225492077 PECOS PAC ID: 2668705757 Enrollment ID: I20211105002696 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Yashaswini Yeragunta |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1528371259 PECOS PAC ID: 6800162819 Enrollment ID: I20211122002114 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Maliha F Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588154371 PECOS PAC ID: 8022400803 Enrollment ID: I20220128001240 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ji-ah Ryu |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1427726116 PECOS PAC ID: 0840684254 Enrollment ID: I20220301001978 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jennifer S Park |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245679182 PECOS PAC ID: 6608163415 Enrollment ID: I20220309002472 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ivy Rose Malit |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750048708 PECOS PAC ID: 9436544228 Enrollment ID: I20220314001059 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Catherine J Gisi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699272195 PECOS PAC ID: 1456739176 Enrollment ID: I20220608000497 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Savannah R Kimball |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1134625866 PECOS PAC ID: 0749669562 Enrollment ID: I20220623003268 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Wilson C Kwan |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1972958775 PECOS PAC ID: 0345506713 Enrollment ID: I20220711001351 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Aviv Tarrab Herzlich |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1588040794 PECOS PAC ID: 0446597827 Enrollment ID: I20220915000861 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Meher F Raza |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1568995868 PECOS PAC ID: 5799030417 Enrollment ID: I20221010000156 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Won Seok Shin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477015949 PECOS PAC ID: 7517334576 Enrollment ID: I20221103001123 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Karthik R Kode |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1689930497 PECOS PAC ID: 5294977377 Enrollment ID: I20221128001990 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Elizabeth M Banach |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245950542 PECOS PAC ID: 9234594656 Enrollment ID: I20230508000986 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Cho Rok Kim |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437787009 PECOS PAC ID: 7517324049 Enrollment ID: I20230526002479 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Soubhi Bahna |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1497069751 PECOS PAC ID: 4183865629 Enrollment ID: I20230605002509 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Jie Pan |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1609369990 PECOS PAC ID: 8820348998 Enrollment ID: I20230623000101 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Audrey Shipei Chen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1790247534 PECOS PAC ID: 8022433945 Enrollment ID: I20230718004229 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Justin Ko |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1689203416 PECOS PAC ID: 7214398056 Enrollment ID: I20230726003392 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Mahsa Madani |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245791243 PECOS PAC ID: 6709230048 Enrollment ID: I20230920003658 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Krixie V Silangcruz |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841857919 PECOS PAC ID: 9234583576 Enrollment ID: I20230920003716 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ronald R Siregar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972124865 PECOS PAC ID: 3375990104 Enrollment ID: I20231115002434 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Zachary A Abelson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1689237414 PECOS PAC ID: 4385092089 Enrollment ID: I20231117002743 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Erica L Flores |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1356802250 PECOS PAC ID: 5799139986 Enrollment ID: I20231208000310 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Isaac D Jenabi |
|---|---|
| Provider Type | Practitioner - Pain Management |
| Provider Identifiers | NPI Number: 1649698218 PECOS PAC ID: 6709111081 Enrollment ID: I20240103003991 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
| Provider Name | Ingrid N Jacob-hicks |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1700270766 PECOS PAC ID: 4789045683 Enrollment ID: I20240216003313 |
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
News Archive
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer's and Parkinson's have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
If you're one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor's first advice is to cut calories-;and especially to cut down on concentrated sugars such as high-fructose corn syrup, a sugar found in sweetened beverages and many other processed foods.
New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.
› Verified 8 days ago
Southbay Endocrine Medical Associates Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 20911 Earl St, Suite 340, Torrance, CA 90503 Phone: 310-802-7002 Fax: 310-542-4695 | |
Delamo Family Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3475 Torrance Blvd Ste G, Torrance, CA 90503 Phone: 310-543-1695 Fax: 310-792-2321 | |
Dunja Maglica Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23441 Madison St Ste 305, Torrance, CA 90505 Phone: 310-378-5115 Fax: 310-378-9779 | |
Torrance Memorial Physician Network Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2900 Lomita Blvd, Torrance, CA 90505 Phone: 310-784-3740 Fax: 310-539-1006 | |
David H. Stern, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1218 Crenshaw Blvd, Torrance, CA 90501 Phone: 310-328-1181 Fax: 310-328-1747 | |
Medical Associates Of Little Company Of Mary Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 21311 Madrona Ave, 100a, Torrance, CA 90503 Phone: 310-792-4400 Fax: 310-542-5805 | |
Bliss Medical Group, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23451 Madison St, Suite 250, Torrance, CA 90505 Phone: 310-791-0083 Fax: 310-791-0085 |